Oncology - Hematology

Episodes 1-15 of 25

• 

  RestartResume

  Neoadjuvant Immunotherapy and Radiation Boosts Response in NSCLC

  Medical Industry Feature

  Neoadjuvant Immunotherapy and Radiation Boosts Response in NSCLC

  • 

    

    Nasser Altorki, MD

    Peer

• 

  RestartResume

  Examining a Therapeutic Modality for 2L+ mNSCLC

  Medical Industry Feature

  Examining a Therapeutic Modality for 2L+ mNSCLC

  • 

    

    Gates B. Colbert, MD

    Peer

  • 

    

    Eric Nadler, MD, MPP

    Peer

• 

  RestartResume

  Evaluating First-Line Therapy for Acute
  Graft-Versus-Host Disease

  Medical Industry Feature

  Evaluating First-Line Therapy for Acute
  Graft-Versus-Host Disease

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Yi Bin Chen, MD

    Peer

  • 

    

    Olaf Penack, MD

    Peer

• 

  RestartResume

  Navigating CLL Treatment: Patient Preferences and Shared Decision-Making

  Medical Industry Feature

  Navigating CLL Treatment: Patient Preferences and Shared Decision-Making

  • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Alexey Danilov, MD, PhD

    Peer

  • 

    

    Brian Koffman, MDCM

    Peer

• 

  RestartResume

  Managing the Complexities of Acute Graft-Versus-Host Disease: Current Challenges and Unmet Needs

  Medical Industry Feature

  Managing the Complexities of Acute Graft-Versus-Host Disease: Current Challenges and Unmet Needs

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Miguel-Angel Perales, MD

    Peer

  • 

    

    Anna Sureda, MD, PhD

    Peer

• 

  RestartResume

  The CLL Patient Journey: From Diagnosis to Initial Treatment

  Medical Industry Feature

  The CLL Patient Journey: From Diagnosis to Initial Treatment

  • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Alexey Danilov, MD, PhD

    Peer

  • 

    

    Brian Koffman, MDCM

    Peer

• 

  RestartResume

  Gene Therapy: Changing the Landscape of Hemophilia B Care

  Medical Industry Feature

  Gene Therapy: Changing the Landscape of Hemophilia B Care

  • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Tammuella Chrisentery-Singleton, MD

    Peer

• 

  RestartResume

  Clinical Insights into Higher-Risk MDS: Treatment Goals and Strategies

  Medical Industry Feature

  Clinical Insights into Higher-Risk MDS: Treatment Goals and Strategies

  • 

    

    Gates B. Colbert, MD

    Peer

  • 

    

    Uma Borate, MD

    Peer

  • 

    

    James Dugan, MD

    Peer

• 

  RestartResume

  EMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i

  Medical Industry Feature

  EMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i

  • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Virginia Kaklamani, MD

    Peer

  • 

    

    Anne O'Dea, MD

    Peer

• 

  RestartResume

  Gene Therapy for Hemoglobinopathies: Focus on Sickle Cell Disease

  Broadcast Replay

  Gene Therapy for Hemoglobinopathies: Focus on Sickle Cell Disease

  • 

    

    Elizabeth Krieger, MD

    Peer

  • 

    

    Nirmish Shah, MD

    Peer

• 

  RestartResume

  Emerging Biomarker Landscape in Gastro/Gastroesophageal Cancer

  Medical Industry Feature

  Emerging Biomarker Landscape in Gastro/Gastroesophageal Cancer

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Steven Maron, MD, MSc

    Peer

• 

  RestartResume

  Considerations for Time-limited Treatment in 1L Treatment Selection Decisions

  Medical Industry Feature

  Considerations for Time-limited Treatment in 1L Treatment Selection Decisions

  • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Matthew Cortese, MD, MPH

    Peer

• 

  RestartResume

  Helping Ensure Adequate Tissue Sampling Within the MDT

  Medical Industry Feature

  Helping Ensure Adequate Tissue Sampling Within the MDT

  • 

    

    Michael Overman, MD

    Peer

  • 

    

    Anil Parwani, MD, PhD

    Peer

• 

  RestartResume

  Pre-Testing: Working Together Toward Testing

  Medical Industry Feature

  Pre-Testing: Working Together Toward Testing

  • 

    

    Michael Overman, MD

    Peer

  • 

    

    Anil Parwani, MD, PhD

    Peer

• 

  RestartResume

  Interpreting Test Results and Making the Treatment Decision Within the MDT

  Medical Industry Feature

  Interpreting Test Results and Making the Treatment Decision Within the MDT

  • 

    

    Michael Overman, MD

    Peer

  • 

    

    Anil Parwani, MD, PhD

    Peer

• 1
• 2
• Next